| Announce Date | 10/23/2025 |
| EPS Normalized Actual | $0.45 (Beat by $0.0955) |
| EPS GAAP Actual | $0.45 (Beat by $0.0955) |
| Revenue Actual | $50.534B |
| Revenue Surprise | Beat by $50534M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.37482 |
| EPS GAAP Estimate | $0.37482 |
| Revenue Estimate | $45.945475B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 2.968 | 4.32 | 2.67684 | 3.25061 | 3 |
| Dec 2028 | 1 | 12.82 | 0.90586 | 1.06945 | 6 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.61 | 0.03622 | 50.534B | 8.58% | 4355.53M |
| FQ2 2025 (Jun 2025) | 0 | -0.43089 | 50.184B | 4.73% | 5339.21M |
| FQ1 2025 (Mar 2025) | 0.12 | 0.12 | 40.659B | -5.21% | 40659M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 48.211B | 4.66% | 48211M |
| FQ3 2024 (Sep 2024) | 0.22 | 0.22 | 46.196B | 5.18% | 46196M |
| FQ2 2024 (Jun 2024) | 0.46 | 0.46 | 47.808B | 5.97% | 47808M |
| FQ1 2024 (Mar 2024) | 0.33 | 0.33 | 42.777B | 3.05% | 42777M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 45.962B | 4.27% | 45962M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.37482
Consensus Revenue Estimates
45.945475B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.39 | -- | 0.33962 | 0.4356 | 4 |
| FQ3 2027 (Sep 2027) | 0.34 | -- | 0.30595 | 0.37313 | 3 |
| FQ2 2027 (Jun 2027) | 0.63 | -- | 0.56691 | 0.69138 | 5 |
| FQ1 2027 (Mar 2027) | 0.12 | -- | 0.10798 | 0.13169 | 3 |
| FQ4 2026 (Oct 2026) | 0.38 | -- | 0.35594 | 0.41164 | 3 |
| FQ3 2026 (Jul 2026) | 0.58 | -5.17 | 0.54328 | 0.62829 | 5 |
| FQ2 2026 (Jun 2026) | 0.47 | -- | 0.42839 | 0.50962 | 4 |
| FQ1 2026 (Mar 2026) | 0.74 | 83.78 | 0.67448 | 0.80239 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 47.09B | -- | 42.41B | 51.33B | 3 |
| FQ3 2027 (Sep 2027) | 44.56B | -- | 41.13B | 47.9B | 2 |
| FQ2 2027 (Jun 2027) | 44.05B | -- | 40.65B | 47.35B | 2 |
| FQ1 2027 (Mar 2027) | 40.44B | -- | 37.33B | 43.47B | 2 |
| FQ4 2026 (Oct 2026) | 46.35B | -- | 44.09B | 49.31B | 2 |
| FQ3 2026 (Jul 2026) | 46.16B | -9.49 | 43.91B | 49.11B | 2 |
| FQ2 2026 (Jun 2026) | 45.64B | -9.95 | 42.54B | 48.6B | 2 |
| FQ1 2026 (Mar 2026) | 46.4B | 12.37 | 43.24B | 49.41B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
1
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.57378 | 0.61 | 0.03622 | 5.94% |
| FQ2 2025 (Jun 2025) | 0.43089 | 0 | -0.43089 | -INF% |
| FQ1 2025 (Mar 2025) | 0.12 | 0.12 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 0.22 | 0.22 | 100% | |
| FQ2 2024 (Jun 2024) | 0.46 | 0.46 | 100% | |
| FQ1 2024 (Mar 2024) | 0.33 | 0.33 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $46.18B | $50.53B | $4355.53M | 8.62% |
| FQ2 2025 (Jun 2025) | $44.84B | $50.18B | $5339.21M | 10.64% |
| FQ1 2025 (Mar 2025) | $0B | $40.66B | $40659M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $48.21B | $48211M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $46.2B | $46196M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $47.81B | $47808M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $42.78B | $42777M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $45.96B | $45962M | 100% |